These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 11991685)

  • 1. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.
    Dermond O; Rüegg C
    Drug Resist Updat; 2001 Oct; 4(5):314-21. PubMed ID: 11991685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-metastatic action of non-steroidal anti-inflammatory drugs.
    Hung WC
    Kaohsiung J Med Sci; 2008 Aug; 24(8):392-7. PubMed ID: 18926952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs.
    Shaheen NJ; Straus WL; Sandler RS
    Cancer; 2002 Feb; 94(4):950-63. PubMed ID: 11920463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA; Dubois RN
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
    Pascucci RA
    J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
    Altinoz MA; Korkmaz R
    Neoplasma; 2004; 51(4):239-47. PubMed ID: 15254653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S; Bamba H; Kato A
    Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.
    Dormond O; Foletti A; Paroz C; Rüegg C
    Nat Med; 2001 Sep; 7(9):1041-7. PubMed ID: 11533708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COX-2 inhibitor and colon cancer].
    Tsujii M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1799-805. PubMed ID: 11729471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS; Derksen E; Gaston K
    J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Tuynman JB; Peppelenbosch MP; Richel DJ
    Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.